Investing
GSK raises $1.24 billion from latest Haleon stake sale
© Reuters. FILE PHOTO: GSK (GlaxoSmithKline) logo is seen in this illustration, August 10, 2022. REUTERS/Dado Ruvic/Illustration/File Photo
(Reuters) – British drugmaker GSK said on Wednesday it had raised 978 million pounds ($1.24 billion) from a discounted stake sale in Haleon, cutting its shareholding to 4.2% in the world’s largest standalone consumer healthcare firm.
GSK sold around 300 million shares in its spun-off unit at a price of 326 pence per share.
($1 = 0.7918 pounds)
Read the full article here
-
Investing7 days ago
Reebok Co-Founder Backs Syntilay’s New AI, 3D-Printed Shoe
-
Side Hustles7 days ago
How to Survive High-Demand Seasons Without Losing Customers
-
Side Hustles5 days ago
5 Things That Could Significantly Impact Your Company in 2025
-
Investing5 days ago
NFI Group surge after board reshaped with new appointments, chairperson By Investing.com
-
Side Hustles7 days ago
Shake It Up — Dunkin’ Debuts Star-Backed Winter Menu
-
Side Hustles6 days ago
How Failing 22 Times Paved the Way to My Success
-
Passive Income4 days ago
3 Challenges Entrepreneurs Will Face in 2025
-
Investing6 days ago
Chinese hack of US telecoms compromised more firms than previously known, WSJ says By Reuters